会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • Prospective identification and characterization of breast cancer stem cells
    • 乳腺癌干细胞的前瞻性鉴定和表征
    • US20070231325A1
    • 2007-10-04
    • US11607780
    • 2006-12-01
    • Michael ClarkeMax WichaMuhammad Al-Hajj
    • Michael ClarkeMax WichaMuhammad Al-Hajj
    • A61K39/395
    • C12N5/0695A01K67/0271A61K39/39558A61K2039/505A61K2039/5152A61K2039/5158C07K14/705C07K14/70585C07K14/71C07K16/28C07K16/2863C07K16/30C12N2501/42C12N2503/00C12N2503/02C12Q1/6886G01N33/5011G01N33/57492
    • A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. Thus, solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. We have developed a xenograft model in which we have been able to establish tumors from primary tumors via injection of tumors in the mammary gland of severely immunodeficient mice. These xenograft assay have allowed us to do biological and molecular assays to characterize clonogenic solid tumor stem cells. We have also developed evidence that strongly implicates the Notch pathway, especially Notch 4, as playing a central pathway in carcinogenesis. This discovery is the basis for solid tumor stem cell compositions, methods for distinguishing functionally different populations of tumor cells, methods for using these tumor cell populations for studying the effects of therapeutic agents on tumor growth, and methods for identifying and testing novel anti-cancer therapies directed to solid tumor stem cells.
    • 建立的实体瘤内的一小部分细胞具有干细胞的特性。 这些实体肿瘤干细胞产生更多的肿瘤干细胞和肿瘤中大部分已经失去广泛增殖能力的细胞和产生新肿瘤的能力。 因此,实体肿瘤异质性反映了由固体肿瘤干细胞产生的肿瘤细胞后代的存在。 我们已经开发了异种移植模型,其中我们已经能够通过在严重免疫缺陷小鼠的乳腺中注射肿瘤来从原发肿瘤中建立肿瘤。 这些异种移植物测定使我们能够进行生物学和分子测定来表征克隆型实体瘤干细胞。 我们还发现证据强烈地暗示Notch途径,特别是Notch 4,作为致癌过程的中心途径。 该发现是实体肿瘤干细胞组合物的基础,区分功能不同的肿瘤细胞群体的方法,使用这些肿瘤细胞群体研究治疗剂对肿瘤生长的影响的方法,以及用于鉴定和测试新型抗癌剂的方法 针对固体肿瘤干细胞的疗法。